ALK-Abelló A/S (ALK-B): Eigentümerstruktur
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 195,9 Dänische Krone | 271,4 Dänische Krone | 192,7 Dänische Krone |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 293,75 Dänische Krone | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 201.622.372 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ALK-Abelló A/S
Mitarbeiter 2.773
Handelsplatz CO
Ticker Symbol ALK-B
IPO Datum -
Adresse Bøge Allé 6-8, Horsholm, Denmark, 2970
Webseite https://www.alk.net
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Peter Halling | President, CEO & Member of Management Board |
| 2 | Mr. Claus Steensen Solje | Executive VP, CFO & Member of Management Board |
| 3 | Mr. Søren Daniel Niegel | Member of Management Board |
| 4 | Ms. Katja Barnkob Thalund | Senior Project Director, Global Clinical Development & Employee-elected Director |
| 5 | Ms. Nanna Rassov Carlson | Senior Manager of QA Release & Employee Representative Director |
| 6 | Mr. Johan Smedsrud | Senior Maintenance Supporter of Process & Production Support & Employee Representative Director |
| 7 | Ms. Lise Lund Maerkedahl | Project Director of Global Clinical Development & Employee-elected Director |
| 8 | Mr. Per Plotnikof | VP of Corporate Communications, Investor Relations & Strategic Planning and Head of IR |
| 9 | Ms. Lika Thiesen | Executive Vice President of Global People & Organisation |
| 10 | Prof. Hendrik Kees Kam Nolte M.D., Ph.D. | Senior Vice President of Research & Development - North America and International Markets |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.